Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 18 11 2019
accepted: 07 06 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 1 9 2020
Statut: epublish

Résumé

3D printing is being used more extensively in modern biomedicine. One of the problems is selecting a proper crosslinking method of bioprinted material. Amongst currently used techniques we can distinguish: physical crosslinking (e.g. Ca2+ and Sr2+) and chemical crosslinking-the UV light crosslinking causing the biggest discussion. UV radiation is selectively absorbed by DNA, mainly in the UV-B region but also (to some extent) in UV-A and UV-C regions. DNA excitement results in typical photoproducts. The amount of strand breaks may vary depending on the period of exposition, it can also differ when cells undergo incubation after radiation. The aim of this study was to show whether and how the time of irradiation with 405 nm and 365 nm wavelengths affect DNA damage in cell lines and micro-organs (pancreatic islets). The degree of DNA damage caused by different wavelengths of radiation (405 nm and 365 nm) was evaluated by a comet assay. The test was performed on fibroblasts, alpha cells, beta cells and porcine pancreatic islets after 24 hours incubation period. Samples without radiation treatment were selected as a control group. Results analysis consisted of determining the percent of cells with damaged DNA and the tail intensity evaluation. The degree of DNA damage in pancreatic islets after exposure to 405 nm wavelength oscillated between 2% and 6% depending on the tested time period (10 - 300 seconds). However, treating islets using 365 nm wavelength resulted in damage up to 50%. This clearly shows significantly less damage when using 405 nm wavelength. Similar results were obtained for the tested cell lines. Crosslinking with 405 nm is better for pancreatic islets than crosslinking with 365 nm UV light.

Identifiants

pubmed: 32584858
doi: 10.1371/journal.pone.0235052
pii: PONE-D-19-31999
pmc: PMC7316267
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235052

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Photodermatol Photoimmunol Photomed. 2001 Apr;17(2):66-70
pubmed: 11338404
J Radiat Res. 2011;52(2):115-25
pubmed: 21436607
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Carcinogenesis. 1997 Apr;18(4):811-6
pubmed: 9111219
Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3268-75
pubmed: 10586952
Ann Biomed Eng. 2015 Mar;43(3):730-46
pubmed: 25476164
Mutat Res. 1998 Aug 7;408(2):111-20
pubmed: 9739813
J Histochem Cytochem. 2005 Sep;53(9):1087-97
pubmed: 15923354
J Endocrinol. 1999 Jun;161(3):357-64
pubmed: 10333538
Angew Chem Int Ed Engl. 2016 Apr 4;55(15):4650-65
pubmed: 26895542
Mutat Res. 2004 Nov 22;556(1-2):25-34
pubmed: 15491629
Biofabrication. 2015 Dec 22;7(4):045009
pubmed: 26696527
J Dermatol Sci. 2002 Nov;30(2):129-35
pubmed: 12413768
Biotechnol Adv. 2016 Jul-Aug;34(4):422-434
pubmed: 26724184
Photochem Photobiol. 1983 Jul;38(1):51-5
pubmed: 6622552
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
Diabetes. 1988 Apr;37(4):413-20
pubmed: 3288530
Photochem Photobiol Sci. 2002 Apr;1(4):225-36
pubmed: 12661961
Islets. 2010 May-Jun;2(3):135-45
pubmed: 20657742
Mol Biotechnol. 2004 Mar;26(3):249-61
pubmed: 15004294
Croat Med J. 2013 Jun;54(3):263-71
pubmed: 23771757
Ann Biomed Eng. 2016 Jun;44(6):2090-102
pubmed: 27184494
Photodermatol Photoimmunol Photomed. 2010 Feb;26(1):16-21
pubmed: 20070834
Mutat Res. 1996 Jun 10;352(1-2):31-8
pubmed: 8676912
Nature. 2003 Jan 23;421(6921):436-40
pubmed: 12540918

Auteurs

M Klak (M)

Foundation of Research and Science Development, Warsaw, Poland.

M Gomółka (M)

Foundation of Research and Science Development, Warsaw, Poland.

T Dobrzański (T)

Foundation of Research and Science Development, Warsaw, Poland.

G Tymicki (G)

Foundation of Research and Science Development, Warsaw, Poland.

P Cywoniuk (P)

Foundation of Research and Science Development, Warsaw, Poland.

P Kowalska (P)

Foundation of Research and Science Development, Warsaw, Poland.

K Kosowska (K)

Foundation of Research and Science Development, Warsaw, Poland.

T Bryniarski (T)

Foundation of Research and Science Development, Warsaw, Poland.

A Berman (A)

Foundation of Research and Science Development, Warsaw, Poland.

A Dobrzyń (A)

Department of Biochemistry, Nencki Institute of Experimental Biology, Warsaw, Poland.

J Idaszek (J)

Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland.

W Święszkowski (W)

Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland.

M Wszoła (M)

Foundation of Research and Science Development, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH